Anika Therapeutics (ANIK) Other Operating Expenses (2010 - 2021)

Anika Therapeutics (ANIK) has 12 years of Other Operating Expenses data on file, last reported at $825000.0 in Q4 2021.

• On a quarterly basis, Other Operating Expenses fell 93.06% year-over-year to $825000.0 in Q4 2021; TTM through Sep 2022 was $825000.0, a 108.22% increase from a year earlier, with the FY2021 full-year figure at -$21.1 million, down 252.27% from the prior year.
• Other Operating Expenses for Q4 2021 stood at $825000.0, up from -$3.4 million in the prior quarter.
• Over the last five years, Other Operating Expenses for ANIK reached as high as $11.9 million in Q4 2020 and fell as low as -$24.3 million in Q4 2018.
• Historically, Other Operating Expenses has averaged $1.0 million across 5 years, with a median of $6.0 million in 2017.
• Across the five-year window, Other Operating Expenses jumped 159.14% in 2020 and slumped 425.31% in 2021, its largest moves.
• Year by year, Other Operating Expenses stood at $8.7 million in 2017, then sank by 378.56% to -$24.3 million in 2018, then rose by 17.22% to -$20.1 million in 2019, then soared by 159.14% to $11.9 million in 2020, then slumped by 93.06% to $825000.0 in 2021.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $825000.0 in Q4 2021, -$3.4 million in Q3 2021, and -$13.6 million in Q2 2021.